Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases

Hisakazu Shiroeda1, Tomomitsu Tahara, Tomoyuki Shibata

  • 1Department of Gastroenterology, Kanazawa Medical University, Uchinada-machi, Ishikawa 920-0293, Japan.

Insights

Macrophage migration inhibitory factor (MIF) gene promoter polymorphisms are linked to duodenal ulcers. Specifically, the 7/7-CATT homozygote genotype increases the risk of developing duodenal ulcers, independent of H. pylori infection.

Area of Science:

  • Genetics
  • Immunology
  • Gastroenterology

Background:

  • Macrophage migration inhibitory factor (MIF) is a critical pro-inflammatory mediator involved in immune and inflammatory diseases.
  • Gastro-duodenal ulcers are common conditions influenced by genetic and environmental factors.

Purpose of the Study:

  • To investigate the association between functional polymorphisms in the MIF gene promoter and the development of gastro-duodenal ulcers.
  • To identify genetic risk factors for duodenal ulcer development.

Main Methods:

  • A case-control study involving 471 DNA samples from healthy volunteers and patients with gastric or duodenal ulcers.
  • Polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) was used to detect MIF gene promoter polymorphisms.
  • Statistical analysis, including unadjusted and adjusted models, was performed to assess associations with ulcer development.

Main Results:

  • Helicobacter pylori (H. pylori) infection, male gender, and NSAID/aspirin use were associated with gastric ulcer risk, but not MIF polymorphisms.
  • H. pylori infection, male gender, and the 7-CATT repeat polymorphism at position -794 of the MIF gene promoter were associated with duodenal ulcer development.
  • The 7/7-CATT homozygote genotype showed a significantly increased risk for duodenal ulcers after adjusting for confounding factors (OR, 6.31; 95% CI, 1.50-26.6; p=0.012).

Conclusions:

  • Tetranucleotide repeat polymorphism in the MIF gene promoter is associated with an increased risk of developing duodenal ulcers.
  • The 7/7-CATT homozygote genotype represents a potential genetic susceptibility factor for duodenal ulcers.
  • Further research is warranted to elucidate the precise mechanisms linking MIF gene polymorphisms to duodenal ulcer pathogenesis.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.